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Abstract: Essential oils are complex mixtures of volatile components produced by the plant
secondary metabolism and consist mainly of monoterpenes and sesquiterpenes and, to a minor
extent, of aromatic and aliphatic compounds. They are exploited in several fields such as perfumery,
food, pharmaceutics, and cosmetics. Essential oils have long-standing uses in the treatment of
infectious diseases and parasitosis in humans and animals. In this regard, their therapeutic potential
against human African trypanosomiasis (HAT) has not been fully explored. In the present work,
we have selected six medicinal and aromatic plants (Azadirachta indica, Aframomum melegueta,
Aframomum daniellii, Clausena anisata, Dichrostachys cinerea, and Echinops giganteus) traditionally used
in Cameroon to treat several disorders, including infections and parasitic diseases, and evaluated the
activity of their essential oils against Trypanosma brucei TC221. Their selectivity was also determined
with Balb/3T3 (mouse embryonic fibroblast cell line) cells as a reference. The results showed that the
essential oils from A. indica, A. daniellii, and E. giganteus were the most active ones, with half maximal
inhibitory concentration (IC50) values of 15.21, 7.65, and 10.50 µg/mL, respectively. These essential
oils were characterized by different chemical compounds such as sesquiterpene hydrocarbons,
monoterpene hydrocarbons, and oxygenated sesquiterpenes. Some of their main components were
assayed as well on T. brucei TC221, and their effects were linked to those of essential oils.
Int. J. Environ. Res. Public Health 2017, 14, 737; doi:10.3390/ijerph14070737 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2017, 14, 737 2 of 16
Keywords: essential oils; African trypanosomiases; Trypanosma brucei; Cameroon; aromatic and
medicinal plants
1. Introduction
For centuries, people living in Africa have been facing various infectious tropical illnesses,
among which African trypanosomiases are some of the most frequent relevant parasitic diseases.
African trypanosomiases, commonly called sleeping sickness in humans (HAT; Human African
Trypanosomiasis) and Nagana in domestic livestock, affect a huge number of people living in poverty
in 36 sub-Saharan countries and hence have a key socioeconomic impact [1–3]. After a century of
outbreaks, due to political instability and a lack of funding, around 70 million people and 50 million
cattle are still at risk of exposure in Africa [4].
Trypanosomiasis is transmitted by the bite of insects from the Glossina spp. (Glossinidae) and is
fatal in humans, if untreated. While taking a blood meal, infected Glossina flies can spread extracellular
protozoans from the species Trypanosoma brucei. There are three morphologically indistinguishable
subspecies of T. brucei. The subspecies T. b. gambiense is responsible for a chronic form of the human
disease, while T. b. rhodesiense causes an acute form, which more rapidly leads to death. Both subspecies
are infective to humans, whereas T. b. brucei is only infective to animals. During the early stage of
the disease or the hemolymphatic phase, the parasite is restricted to the blood and lymph, and, after
months or years, it invades the central nervous system, resulting in various neurological symptoms,
including sleeping disturbance [3].
As for other neglected tropical diseases, the chemotherapeutical arsenal against HAT is based
on limited, expensive, and often toxic medicines that are administered parentally in a context of
poverty and a lack of qualified personnel in healthcare centers. The few drugs that are available are
pentamidine and suramin for the early stage of the disease and eflornithine (also in combination
with nifurtimox) and melarsoprol, an organoarsenic compound, for the late stage, when the parasite
infects the brain. Although melarsoprol can cause severe reactive encephalopathy, it remains a first line
treatment for infections by T. b. gambiense in many rural areas because of the high cost of eflornithine [1].
Overall, the scenario described above highlights the critical nature of the current situation and the
urgent need to explore new sources of potentially effective and safe compounds for therapy.
It has been estimated that a large part of the African population relies on herbal medicines
as the first-line treatment for different ailments. In this regard, the African flora represents a
valuable source of anti-infectious compounds to be exploited as drugs [5–7]. In the fight against
Trypanosoma infections, new therapeutic options can be provided by plant extracts, essential oils, and
plant-borne compounds [6,8–10]. Essential oils are volatile mixtures distilled from aromatic plants
and composed of several dozens of components such as terpenoids, phenylpropanoids, and aliphatic
compounds [11,12]. In recent years, an increasing interest on essential oils as alternative/integrative
therapies in the treatment of HAT has been observed [13]. Essential oils and representative
components from lemongrass (Cymbopogon citratus (DC.) Stapf), oregano (Origanum vulgare L.), thyme
(Thymus vulgaris L.), clove (Syzygium aromaticum (L.) Merr. and L.M. Perry), basil (Ocimum basilicum L.),
and yarrow (Achillea millefolium L.) exhibited efficacy both in in vitro and in vivo models of
trypanosomal infections [14]. Essential oils are composed of a plethora of chemical compounds,
which have various modes of action on microorganisms, and, additionally, essential oils do not induce
any form of resistance [15].
In the present study, we selected a panel of Cameroonian medicinal and aromatic plants
as potential sources of anti-trypanocidal compounds. We focused on Azadirachta indica A. Juss
(Meliaceae), Aframomum melegueta K. Schum. (Zingiberaceae), Aframomum daniellii (Hook. F.) K.
Schum. (Zingiberaceae), Clausena anisata (Willd.) Hook.f. ex Benth. (Rutaceae), Dichrostachys cinerea
(L.) Wight and Arn. (Mimosaceae), and Echinops giganteus A. Rich. (Asteraceae).
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A. indica, also known as ‘neem tree‘, is considered by many people living in Africa as a
miraculous plant for a wide range of uses in ethnopharmacology such as anthelmintic, antimalarial,
anti-inflammatory purposes and for healing skin diseases. Most of these properties were then
confirmed by scientific reports [16–18]. All parts of the plant can be used for medicinal purposes,
including the seed oil extracted by mechanical pressure [19,20]. Notably, the ethanolic extract obtained
from neem stem bark exhibited activity against T. b. brucei [21], whereas the leaf essential oil has been
barely investigated to date.
A. melegueta, also known as ‘alligator pepper’ or ‘grain of paradise’, is a perennial plant native
to western Africa, and its seeds are used as a spice in food due to their aromatic flavor and pungent
taste or as ingredients of ethnomedical preparations for the treatment of snakebites, stomachaches,
and diarrhea [22]. Antimicrobial, anti-inflammatory, anticancer, and antioxidant properties have been
reported for alligator pepper [23]. Concerning seed volatile constituents, they showed repellent activity
against adults of the maize weevil Sitophilus zeamais [24].
A. daniellii, also known as ‘African cardamom’, is an herbaceous plant traditionally used in Africa
as a spice due to the pungent taste of its seeds, whereas, for medicinal purposes, the plant is employed
as a laxative and for curing parasitic and other microbial infections [25,26]. The anti-inflammatory effect
of its seed essential oil and the preservative properties in stored grains have also been reported [27,28].
C. anisata is an evergreen tropical tree up to 10 m tall with leaves containing secretory glands and
emitting a strong smell [29]. In Africa, it is considered highly effective against insects and has also
been used in the treatment of malaria [30].
D. cinerea is a tree growing in tropical areas in countries such as Cameroon, Kenya, South
Africa, and Tanzania, where a decoction of its leaves and roots is used against venereal disease, eye
inflammations, skin diseases, and snake bites. The root is used for chest complaints and the twigs for
gonorrhoea and syphilis. The essential oil was toxic to mosquito vectors of bancroftian filariasis [26].
E. giganteus is a perennial herb widely used in African traditional medicine for the treatment
of various ailments [31,32]. In previous studies, the root methanolic extract showed significant
antibacterial [33], antifungal [34], and antioxidant effects [35]. The cytotoxicity of the crude methanol
extract from the roots has also been demonstrated [36,37].
Overall, these Cameroonian plants are also traditionally used to control populations of arthropod
pests [38–40]. In this research, we shed light on the growth inhibitory potential of the essential oils
obtained from the leaves of A. indica, A. daniellii, and C. anisata; the seeds of A. melegueta and D. cinerea;
and the roots of E. giganteus against T. brucei TC221. Selected pure constituents from the above
mentioned essential oils were also evaluated.
2. Materials and Methods
2.1. Plant Material
Leaves of A. indica were collected during the dry season (January 2016) from a tree in the city
of Guidiguis (north of Cameroon), about 70 km from Maroua. The leaves were air-dried in the
shade for one week and kept in papers. Fruits (pods) of A. melegueta were collected in a forest near
Foumbam (western Cameroon) in December 2015. Once harvested, the seeds were removed from
their pods and dried at room temperature over a period of three weeks in the absence of sunlight.
At the end of the drying process, the seeds were placed into paper bags before hydrodistillation.
Leaves of C. anisata were collected in the village of Baffou, Menoua Division, Western Cameroon.
Leaves of A. danielli and fruits of D. cinerea and roots of E. giganteus were collected from Bamougoum
and Bafoussam’s market (Cameroon, Western Region), respectively. The pericarp of D. cinerea was
removed and the seeds used; the roots of E. giganteus were washed with water and sliced into small
pieces. These plant parts were dried at room temperature for one week. The botanical identification
of the five species was performed by a taxonomist at the Cameroon National Herbarium (Yaoundé,
Cameroon), and the voucher specimens were archived with the following codes: 4447 SRFK (A. indica),
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43117 HNC (A. melegueta), 43130 HNC (A. danielli), 44242/HNC (C. anisata), 42920 HNC (D. cinerea),
and 23647 SRF (E. giganteus). The botanical names were also checked against The Plant List database
(www.theplantlist.org).
2.2. Isolation of Essential Oil
The dry leaves of A. indica, A. daniellii, and C. anisata; the seeds of A. melegueta and D. cinerea;
and the roots of E. giganteus were cut into small pieces and subjected to hydrodistillation using a
Clevenger-type apparatus until no more oil was obtained. The essential oils obtained were dried using
Na2SO4 and stored at −20 ◦C in vials sealed with teflon caps and protected from light before use. The
oil yields were calculated on a dry weight basis (%, w/w).
2.3. Chemicals
For the identification of volatiles, the following analytical standards purchased from Sigma
Aldrich (Milan, Italy) were used: α-pinene, β-pinene, sabinene, 1,8-cineole, camphene, myrcene,
α-phellandrene, δ-3-carene, p-cymene, limonene, γ-terpinene, terpinolene, linalool, trans-pinocarveol,
terpinen-4-ol, α-terpineol, myrtenal, citronellol, isobornyl acetate, (E)-caryophyllene, α-humulene,
(E)-β-ionone, and caryophyllene oxide. The reference drug suramin was purchased from
Sigma Aldrich.
2.4. Gas Chromatography–Mass Spectrometry (GC-MS) Analysis of Essential Oils
The chemical constituents of the Cameroonian essential oils were analyzed on an Agilent 6890 N
gas chromatograph coupled to a 5973 N mass spectrometer (Santa Clara, CA, USA) and equipped with
a HP-5 MS capillary column (5% phenylmethylpolysiloxane, 30 m, 0.25 mm i.d., 0.1 µm film thickness;
J & W Scientific, Folsom, CA, USA). For the separation of the volatile constituents, the following
temperature program was used: 5 min at 60 ◦C then 4 ◦C/min up to 220 ◦C, then 11 ◦C/min up to
280 ◦C held for 15 min. The injector and detector temperatures were: 280 ◦C; carrier gas: Helium; flow
rate: 1 mL/min; split ratio: 1:50; acquisition mass range: 29–400 m/z; and mode: electron-impact (EI,
70 eV). The essential oil was diluted 1:100 in n-hexane, and then 2 µL of the solution was injected into
the GC-MS system. For the identification of essential oil components, co-injection with the authentic
standards available in our laboratory (purchased from Sigma-Aldrich) was performed, together with
a comparison of the retention indices and the mass spectra of those occurring in the ADAMS, NIST
08, and FFNSC2 libraries [41–43]. The percentage values of the volatile components were the means
of three chromatographic analyses and were determined from the peak areas without the use of
correction factors.
2.5. T. brucei and Mammalian Cell Culture and Growth Inhibition Assay
The cell culture conditions and the growth inhibition assay on T. brucei and Balb/3T3 cells were
performed as described before [44]. T. brucei TC221 bloodstream forms and mouse embryonic fibroblast
Balb/3T3 cells (ATCC no CCL-163) were cultivated in vented plastic flasks at 37 ◦C with 5% CO2.
For T. brucei, the growth medium was HMI-9 [45] supplemented with 10% (v/v) fetal bovine serum
(Gibco, Waltham, MA, USA), whereas the Balb/3T3 cells were grown in Dulbecco’s Modified Eagle’s
Medium (Sigma-Aldrich) supplemented with 10% (v/v) heat-inactivated fetal bovine serum, glutamine
(0.584 g/L), and 10 mL/L 100× penicillin-streptomycin (Gibco).
The essential oils or pure compounds identified from these oils were dissolved in dimethyl
sulfoxide (DMSO) and serially diluted with growth medium in white 96-well microtiter plates.
20,000 bloodstream forms of T. brucei or Balb/3T3 cells were added to each well in a final volume of
200 µL. In the case of mammalian cells, we also tested 2000 cells/well with similar results. To avoid
any damage to the cells, the concentration of DMSO in the solution was never higher than 1% (no cell
growth inhibition was observed with this concentration of DMSO). Cell viability was verified by a
drug-free control for each compound.
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The plates were incubated for 48 h in the CO2 incubator; then 20 µL of 0.5 mM resazurine (Sigma
Aldrich) was added to each well, and the plates were incubated for an additional 24 h before the
fluorescence was measured with an Infinite M200 microplate reader (Tecan group, Ltd., Männedorf,
Switzerland) equipped with 540 and 590 nm excitation and emission filters. The half maximal inhibitory
concentration (IC50) values were calculated on a log inhibitor versus the response curves by non-linear
regression using the GraphPad prism 5.04 software (GraphPad Software, Inc., La Jolla, CA, USA).
3. Results and Discussion
3.1. Chemical Composition of Essential Oils from Cameroonian Plants
The chemical composition of the essential oils hydrodistilled from the six Cameroonian medicinal
and aromatic plants is reported in Table 1. In the essential oil obtained from neem leaves, a total
of thirteen components were identified, accounting for 98.3% of the total composition. The oil was
almost entirely composed by sesquiterpene hydrocarbons (97.4%), with germacrene B (74.0%) and
γ-elemene (18.3%) as the predominant components. The minor constituents were (E)-caryophyllene
(2.4%) and β-elemene (0.9%). This work represents one of the few studies on the chemical composition
of neem leaf essential oils. Neem trees have been largely investigated for the oil obtained by mechanical
pressure or solvent extraction from their seeds. Earlier, El-Hawary et al. [46] studied the composition
of Egyptian neem leaves, reporting β-elemene (33.39%), γ-elemene (9.89%), germacrene D (9.72%),
caryophyllene (6.8%), and bicyclogermacrene (5.23%) as the major compounds, while Dastan et al. [47]
found γ-elemene (20.8%), germacrene B (20.3%), trans-caryophyllene (13.5%), hexadecanal (12.8%),
and methyl linoleate (10.5%) as the major compounds in neem leaf oil from Iran.
A total of fifty-nine components were identified in the essential oil of alligator pepper, accounting
for 99.4% of the total composition. The oil was dominated by oxygenated monoterpenes (83.3%), with
1,8-cineole (58.5%) and α-terpineol (19.4%) as the major compounds. Monoterpene hydrocarbons gave
a minor contribution (14.9%), with β-pinene (7.1%) and α-pinene (2.0%) as the most representative
compounds. Interestingly, sesquiterpenoids, which are reported as volatile marker compounds of
alligator pepper, were detected in only low levels here (0.6%). The chemical composition of the
A. melegueta seed essential oil showed a significant variability depending on the geographic origin
and genetic characteristics of the samples. For example, samples from Nigeria exhibited humulene
(26.23%), (E)-ocimene (23.22%), (E)-caryophyllene (19.17%), and (S)-2-heptyl acetate (16.22%) as the
major volatile constituents [24]. On the other hand, the seeds from the Central African Republic
contained high levels of β-pinene (>30%) and about 50% sesquiterpene hydrocarbons [48], and an
oil sample from Cameroon was made up of β-caryophyllene (8.5%), α-humulene (31.3%), and their
epoxides (17.9% and 27.7%, respectively) [49].
Fifty-seven compounds were identified in the essential oil from African cardamom leaves,
accounting for 99.3% of the total composition. This oil was mainly made up of monoterpene
hydrocarbons (59.8% in leaves), accompanied by lower amounts of sesquiterpene hydrocarbons (20.0%),
oxygenated monoterpenes (11.0%), and oxygenated sesquiterpenes (8.4%). The major compounds were
sabinene (43.9%) and (E)-caryophyllene (16.6%), whereas other components occurring at noteworthy
levels were β-pinene (5.8%), terpinen-4-ol (3.7%), and α-pinene (2.4%). This study was the first report
on the leaf essential oil from A. daniellii.
The essential oil extracted from the leaves of C. anisata was characterized by high levels of
phenylpropanoids (84.0%), which were mainly represented by (E)-anethole (64.6%), with minor
contributions by (E)-methyl isoeugenol (16.1%) and methyl chavicol (2.0%). Terpenoids constituted
a minor part of this oil, being represented mostly by p-cymene (2.9%), γ-terpinene (2.4%), myrcene
(2.0%), and germacrene D (2.2%).
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Table 1. Chemical composition of the essential oils from Azadirachta indica, Aframomum melegueta, Aframomum daniellii, Clausena anisata, Dichrostachys cinerea, and
Echinops giganteus.
No. Component a RI calc. b RI lit. c
% d
ID fAzadirachta
indica
Aframomum
melegueta
Aframomum
daniellii e
Clausena
anisata
Dichrostachys
cinerea e
Echinops
giganteus e
1 isopentyl acetate 873 869 tr g RI,MS
2 2-methyl butyl acetate 876 875 tr RI,MS
3 2-heptanone 891 892 tr RI,MS
4 2-heptanol 901 894 0.2 RI,MS
5 α-thujene 916 924 tr 1.0 0.1 RI,MS
6 α-pinene 921 932 2.0 2.4 0.2 tr Std
7 α-fenchene 938 945 0.1 RI,MS
8 camphene 939 946 0.3 tr RI,MS
9 sabinene 959 969 tr 43.9 0.6 RI,MS
10 β-pinene 963 974 7.1 5.8 0.3 0.1 Std
11 dehydro-1,8-cineole 979 988 0.1 RI,MS
12 myrcene 982 988 0.2 1.5 2.0 0.3 tr Std
13 α-phellandrene 996 1004 0.3 tr Std
14 δ-3-carene 1003 1008 tr Std
15 α-terpinene 1009 1014 0.3 0.9 tr RI,MS
16 p-cymene 1016 1020 1.1 1.0 2.9 0.1 Std
17 limonene 1020 1024 1.5 0.7 0.4 tr tr Std
18 1,8-cineole 1021 1026 58.5 0.5 0.2 2.3 Std
19 ethylhexanol 1031 1030 0.2 RI,MS
20 (Z)-β-ocimene 1037 1032 0.4 Std
21 (E)-β-ocimene 1041 1044 0.1 0.3 0.3 RI,MS
22 γ-terpinene 1050 1054 0.9 1.9 2.4 Std
23 cis-sabinene hydrate 1057 1065 1.1 RI,MS
24 cis-linalool oxide 1071 1067 tr 0.1 RI,MS
25 terpinolene 1079 1086 0.8 0.4 0.1 tr Std
26 p-cymenene 1086 1089 0.2 RI,MS
27 ligustrazin 1081 1083 5.1 RI,MS
28 trans-sabinene hydrate 1089 1098 0.9 RI,MS
29 2-nonanone 1094 1094 tr RI,MS
30 linalool 1096 1095 tr 1.8 tr 4.0 Std
31 n-nonanal 1105 1100 tr RI,MS
32 endo-fenchol 1108 1114 0.3 RI,MS
33 cis-p-menth-2-en-1-ol 1113 1118 0.2 0.3 RI,MS
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Table 1. Cont.
No. Component a RI calc. b RI lit. c
% d
ID fAzadirachta
indica
Aframomum
melegueta
Aframomum
daniellii e
Clausena
anisata
Dichrostachys
cinerea e
Echinops
giganteus e
34 α-campholenal 1123 1122 tr 0.1 RI,MS
35 trans-pinocarveol 1128 1135 0.2 0.7 Std
36 trans-p-menth-2-en-1-ol 1131 1136 0.1 0.3 RI,MS
37 cis-β-terpineol 1142 1140 tr RI,MS
38 cis-verbenol 1142 1137 0.2 RI,MS
39 trans-pinocamphone 1151 1158 0.4 RI,MS
40 pinocarvone 1152 1160 tr 0.1 RI,MS
41 borneol 1156 1165 0.2 0.7 Std
42 p-mentha-1,5-dien-8-ol 1158 1166 1.1 RI,MS
43 cis-pinocamphone 1162 1172 0.8 RI,MS
44 umbelullone 1166 1167 3.8 RI,MS
45 terpinen-4-ol 1167 1174 1.4 3.7 tr 7.5 Std
46 cis-pinocarveol 1175 1182 tr RI,MS
47 cryptone 1183 1183 tr RI,MS
48 p-cymen-8-ol 1178 1179 tr tr 0.3 RI,MS
49 α-terpineol 1181 1186 19.4 0.2 tr 3.3 Std
50 myrtenal 1184 1195 0.2 0.1 0.2 Std
51 myrtenol 1186 1194 0.2 0.4 1.1 Std
52 cis-piperitol 1199 1195 tr RI,MS
53 γ-terpineol 1195 1199 tr RI,MS
54 methyl chavicol 1196 1195 2.0 RI,MS
55 trans-piperitol 1205 1207 0.1 RI,MS
56 trans-carveol 1217 1215 tr 0.2 RI,MS
57 cis-carveol 1228 1226 tr RI,MS
58 thymol methyl ether 1224 1232 tr RI,MS
59 nerol 1229 1227 0.2 Std
60 citronellol 1231 1223 0.3 Std
61 carvone 1240 1239 tr Std
62 carvacrol methyl ether 1237 1241 tr RI,MS
63 neral 1241 1235 0.2 Std
64 piperitone 1250 1249 0.3 RI,MS
65 (Z)-anethole 1250 1249 0.3 RI,MS
66 p-anisaldehyde 1251 1247 0.7 RI,MS
67 geraniol 1251 1249 18.2 Std
68 trans-ascaridol glycol 1262 1266 tr RI,MS
69 (E)-cinnamaldehyde 1267 1267 tr RI,MS
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Table 1. Cont.
No. Component a RI calc. b RI lit. c
% d
ID fAzadirachta
indica
Aframomum
melegueta
Aframomum
daniellii e
Clausena
anisata
Dichrostachys
cinerea e
Echinops
giganteus e
70 phellandral 1269 1273 0.1 RI,MS
71 isobornyl acetate 1276 1283 tr Std
72 (E)-anethole 1287 1282 64.6 Std
73 thymol 1291 1289 0.1 0.9 Std
74 trans-sabinyl acetate 1291 1289 tr RI,MS
75 methyl myrtenate 1292 1293 2.0 RI,MS
76 carvacrol 1301 1298 0.5 tr 0.7 Std
77 cis-pinocarvyl acetate 1303 1311 0.1 RI,MS
78 myrtenyl acetate 1316 1324 1.9 RI,MS
79 silphiperfol-5-ene 1318 1326 2.1 RI,MS
80 δ-elemene 1326 1335 0.1 0.1 RI,MS
81 presilphiperfol-7-ene 1328 1334 7.8 RI,MS
82 silphinene 1333 1340 1.7 RI,MS
83 7-epi-silphiperfol-5-ene 1336 1349 3.5 RI,MS
84 α-terpinyl acetate 1341 1346 tr 0.3 RI,MS
85 α-copaene 1362 1374 0.2 0.2 tr Std
86 β-bourbonene 1369 1387 0.3 tr RI,MS
87 modheph-2-ene 1362 1382 3.0 RI,MS
88 silphiperfol-6-ene 1373 1377 23.0 RI,MS
89 β-bourbonene 1377 1387 0.1 RI,MS
90 β-cubebene 1377 1387 tr RI,MS
91 α-isocomene 1379 1387 2.4 RI,MS
92 β-elemene 1380 1389 0.9 tr 0.1 Std
93 decanoic acid 1380 1386 2.8 RI,MS
94 anisyl methyl ketone 1382 1380 0.1 RI,MS
95 iso-longifolene 1383 1389 tr RI,MS
96 β-isocomene 1400 1407 2.1 RI,MS
97 α-gurjunene 1400 1409 tr Std
98 (E)-caryophyllene 1402 1417 2.4 tr 16.6 0.8 6.3 Std
99 methyl eugenol 1406 1403 0.3 RI,MS
100 α-trans-bergamotene 1425 1432 0.1 RI,MS
101 isoamyl benzoate 1433 1433 tr RI,MS
102 γ-elemene 1427 1434 18.3 0.1 RI,MS
103 α-humulene 1436 1452 0.4 tr 1.5 0.8 2.0 Std
104 geranyl acetone 1449 1453 1.2 RI,MS
105 (E)-β-farnesene 1450 1454 tr tr RI,MS
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Table 1. Cont.
No. Component a RI calc. b RI lit. c
% d
ID fAzadirachta
indica
Aframomum
melegueta
Aframomum
daniellii e
Clausena
anisata
Dichrostachys
cinerea e
Echinops
giganteus e
106 germacrene D 1465 1484 0.5 0.3 2.2 0.3 RI,MS
107 selina-4,11-diene 1467 1474 0.1 RI,MS
108 β-selinene 1469 1489 tr RI,MS
109 ar-curcumene 1472 1479 tr 0.1 RI,MS
110 bicyclogermacrene 1480 1500 0.1 0.1 RI,MS
111 benzaldehyde, 3,4-dimethoxy- 1482 1489 0.2 RI,MS
112 (E)-β-ionone 1481 1487 0.5 Std
113 epi-cubebol 1489 1493 0.1 RI,MS
114 α-zingiberene 1492 1493 0.1 RI,MS
115 (Z)-α-bisabolene 1493 1506 0.1 RI,MS
116 silphiperfolan-6-α-ol 1496 1507 1.0 RI,MS
117 β-bisabolene 1498 1505 0.9 RI,MS
118 (E)-methyl isoeugenol 1499 1491 16.1 RI,MS
119 cameroonan-7-α-ol 1500 1510 7.1 RI,MS
120 β-bisabolene 1506 1505 0.3 RI,MS
121 7-epi-α-selinene 1507 1520 tr RI,MS
122 (E,E)-α-farnesene 1508 1505 0.3 Std
123 trans-calamenene 1508 1521 tr RI,MS
124 δ-cadinene 1510 1522 0.2 tr 0.1 0.3 RI,MS
125 silphiperfolan-7-β-ol 1510 1519 2.5 RI,MS
126 β-sesquiphellandrene 1520 1521 tr RI,MS
127 selina-3,7(11)-diene 1531 1545 0.2 RI,MS
128 silphiperfolan-6-β-ol 1535 1546 1.7 RI,MS
129 hedycaryol 1536 1546 1.5 RI,MS
130 germacrene B 1546 1559 74.0 0.3 RI,MS
131 elemicin 1556 1555 3.0 RI,MS
132 (E)-nerolidol 1556 1561 0.7 Std
133 isoaromadendrene epoxide 1560 1572 1.8 RI,MS
134 prenopsan-8-ol 1564 1575 3.2 RI,MS
135 caryophyllene oxide 1564 1582 2.2 1.1 Std
136 (3Z)-hexenyl benzoate 1566 1565 0.3 RI,MS
137 spathulenol 1568 1576 0.1 RI,MS
138 presilphiperfolan-8-ol 1578 1585 22.7 MS
139 guaiol 1583 1600 0.5 RI,MS
140 humulene epoxide II 1590 1608 0.1 tr RI,MS
141 10-epi-γ-eudesmol 1600 1622 tr 0.3 RI,MS
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Table 1. Cont.
No. Component a RI calc. b RI lit. c
% d
ID fAzadirachta
indica
Aframomum
melegueta
Aframomum
daniellii e
Clausena
anisata
Dichrostachys
cinerea e
Echinops
giganteus e
142 eremoligenol 1611 1629 0.4 RI,MS
143 γ-eudesmol 1615 1630 tr 0.4 RI,MS
144 1,10-di-epi-cubenol 1619 1618 0.1 RI,MS
145 β-eudesmol 1631 1649 0.2 1.5 RI,MS
146 α -acorenol 1628 1632 1.0 RI,MS
147 caryophylla-4(12),8(13)-dien-5-olh 1630 1639 0.2 tr RI,MS
148 epi-α -muurolol 1635 1640 tr 0.7 0.4 RI,MS
149 α -muurolol 1640 1644 0.1 RI,MS
150 α -eudesmol 1636 1652 0.5 RI,MS
151 intermedeol 1639 1666 0.1 RI,MS
152 α-cadinol 1647 1652 tr 1.4 0.4 RI,MS
153 ageratochromene 1655 1658 0.8 RI,MS
154 α-bisabolol 1673 1685 tr 0.4 Std
155 3-oxo-β-ionone 1678 1685 0.9 RI,MS
156 cyperotundone 1688 1695 0.9 RI,MS
157 (2E-6Z)-farnesol 1709 1698 2.4 RI,MS
158 curcuphenol 1716 1717 0.4 RI,MS
159 (2E-6Z)-farnesal 1718 1713 1.0 RI,MS
160 (2E-6E)-farnesal 1737 1740 1.7 RI,MS
161 n-tricosane 2300 2300 0.1 Std
Oil yield (%) 0.01 0.3 0.2 2.0 0.4 1.8
Total identified (%) 98.3 99.4 99.3 99.6 76.0 94.3
Grouped compounds (%)
Monoterpene hydrocarbons 14.9 59.8 0.6 0.6 tr
Oxygenated monoterpenes 83.3 11.0 0.3 50.6
Sesquiterpene hydrocarbons 97.4 0.2 20.0 5.2 54.7
Oxygenated sesquiterpenes 0.4 8.4 0.2 12.1 39.6
Phenylpropanoids 84.0
Others 0.9 0.6 0.2 12.7
a Components are reported in order of their elution from an HP-5MS capillary column; b Retention index (RI) experimentally determined using a mixture of C8-C30 of n-alkanes; c Retention
index taken from ADAMS [41] and/or NIST 08 [42] for an apolar capillary column; d Relative percentage values are means of three determinations with a Relative Standard Deviation
(RSD%) below 15% for the most abundant components; e Analytical data are taken from Pavela et al. [26]; f Identification methods: standard (std), based on the comparison of RT (retention
time), RI, and MS (mass spectronomy) with authentic compounds; RI, based on correspondence of calculated RI with those reported in ADAMS and NIST 08; MS, based on comparison
with the WILEY, ADAMS, FFNSC2, and NIST 08 MS databases; g traces, % <0.1; h Correct isomer not identified. ID: Identity.
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In the essential oil of D. cinerea seeds, a total of forty-nine volatile components were identified,
accounting for 76.0% of the oil’s composition. Oxygenated monoterpenes were the most abundant
constituents (50.6%), with geraniol (18.2%), terpinen-4-ol (7.5%), linalool (4.0%), and umbellulone
(3.8%) as the most representative compounds. Oxygenated sesquiterpenes gave a lower contribution
(12.1%), with none of the identified components exceeding 1.8%. Among other components occurring
in the oil, it is worth noting the presence of ligustrazin (5.1%), elemicin (3.0%), and decanoic acid
(2.8%). To our knowledge, no previous research has reported the chemical composition of D. cinerea
seed essential oil.
Thirty-five volatile compounds, all belonging to the sesquiterpene class (94.3%), were identified
in the root essential oil from E. giganteus (54.7% sesquitepene hydrocarbons and 39.6% oxygenated
sesquiterpenes). The major compounds were tricyclic sesquiterpenoids, which are characterized
by multiple rearrangements of the caryophyllene cation [50,51], namely, silphiperfol-6-ene (23.0%),
presilphiperfolan-8-ol (22.7%), presilphiperfol-7-ene (7.8%), and cameroonan-7-α-l (7.8%). Another
noteworthy constituent occurring in the oil was (E)-caryophyllene (6.3%). The cameroonan-7-α-l,
is responsible for the patchouli-like smell of the root oil [52]. The reported composition was quite
consistent with that previously reported by Menut et al. [49] for root samples collected in Cameroon.
3.2. Inhibition of Trypanosoma brucei Proliferation
Essential oils are complex mixtures of volatile compounds with multitarget actions, the
antitrypanosomal effects of which are largely unknown and barely explored. On this basis, we
decided to test the in vitro inhibitory effects of a pool of essential oils taken from medicinal and
aromatic plants growing in Cameroon. Some of them are known for their traditional uses in the
treatment of infectious diseases and malaria [53,54] and, in the case of the Neem tree, also against
T. b. brucei [21].
Based on the chemical analysis performed, they exhibited different chemical profiles characterized
by diverse functionalized groups such as monoterpene hydrocarbons (African cardamom), oxygenated
monoterpenes (A. melegueta and D. cinerea), sesquiterpene hydrocarbons (A. indica), sesquiterpene
hydrocarbons and oxygenated sesquiterpenes (E. giganteus), and phenylpropanoids (C. anisata). In this
context, the main aim of our work was to identify the chemical scaffolds of possible natural lead
compounds against trypanosomiasis.
Testing the essential oils obtained from Cameroonian plants, we obtained various degrees of
inhibition on T. brucei proliferation, varying from not active (A. melegueta, C. anisata, and D. cinerea), to
moderately active (A. danielli, E. giganteus and A. indica). Notably, the IC50 values on T. brucei were 7.65,
10.50, and 15.21 µg/mL for the essential oils from A. danielli, E. giganteus, and A. indica, respectively
(Table 2). Furthermore, the most active oils were also evaluated for the growth inhibitory effects on
Balb/3T3 cells as a reference. No effect on mammalian cells was observed with concentrations as high
as 100 µg/mL, showing a noteworthy selectivity against T. brucei in comparison to mammalian cells,
with selectivity indexes above 6.57 in all cases.
The inhibitory effects on T. brucei exhibited by the three essential oils highlights three classes of
active compounds, i.e., monoterpene hydrocarbons (for A. danielli) and sesquiterpene hydrocarbons (for
A. indica and E. giganteus) (Figure 1). E giganteus also contains high amounts of oxygenated compounds.
The toxicity of monoterpene hydrocarbons against T. brucei can be attributed to the high
hydrophobicity of this class of compounds, which are able to easily cross the cell membrane, causing
the destabilization of phospholipid bilayers and the alteration of their permeability, leading to cell
damage and death [44,55]. Among these compounds, the most abundant was sabinene (43.9%)
(Figure 1) which showed an IC50 value against T. brucei of 5.96 µg/mL, which is close to that of the
African cardamom essential oil (7.65 µg/mL) (Table 2). Another component of this oil with detectable
antitrypanosomal activity was β-pinene, showing an IC50 value of 11.4 µg/mL. The antitrypanosomal
activity of sabinene was already reported in a previous study, although its mechanism of action on the
protozoal cell has not been elucidated [56].
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Table 2. Inhibitory effects of essential oils from Cameroonian plants against Trypanosoma brucei brucei
TC221 and Balb/3T3 cells.
Treatment
IC50 (µg/mL)
Selectivity Index (SI)
T. b. brucei (TC221) Balb/3T3
Essential oils
Aframomum danielli 7.65 ± 1.1 >100 >13.1
Dichrostachys cinerea >100 - -
Echinops giganteus 10.50 ± 1.7 >100 >9.52
Azadirachta indica 15.21 ± 0.97 >100 >6.57
Aframomum melegueta >100 - -
Clausena anisata >100 - -
Pure compounds µg/mL (µM) µg/mL (µM)
Sabinene 5.96 ± 1.3 (43.8) >100 >16.7
β-Pinene 11.4 ± 2.6 (83.7) >100 >8.77
1,8-Cineole >100 -
Terpinen-4-ol >100 -
(E)-Caryophyllene 8.25 ± 1.3 (40.4) >100 >12.1
Reference drug µg/mL (µM) µg/mL (µM)
Suramin 0.0286 ± 0.0008 (0.0220) -
IC50: half maximal inhibitory concentration.
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Figure  1. Chemical  structures of  the main  essential oil  constituents  in  (a) Aframomum daniellii,  (b) Echinops 
giganteus, and (c) Azadirachta indica. 
The  toxicity  of monoterpene  hydrocarbons  against  T.  brucei  can  be  attributed  to  the  high 
hydrophobicity of this class of compounds, which are able to easily cross the cell membrane, causing 
the destabilization of phospholipid bilayers and the alteration of their permeability, leading to cell 
damage  and  death  [44,55]. Among  these  compounds,  the most  abundant was  sabinene  (43.9%) 
(Figure 1) which showed an IC50 value against T. brucei of 5.96 μg/mL, which is close to that of the 
African cardamom essential oil (7.65 μg/mL) (Table 2). Another component of this oil with detectable 
antitrypanosomal activity was β‐pinene, showing an IC50 value of 11.4 μg/mL. The antitrypanosomal 
activity of sabinene was already reported in a previous study, although its mechanism of action on 
the protozoal cell has not been elucidated [56]. 
E.  giganteus  as  well  as  A.  daniellii  essential  oils  contained  the  bicyclic  sesquiterpene  (E)‐
caryophyllene  (Figure  1), which  exhibited  good  inhibitory  properties  on  T.  brucei  (IC50  value  of   
8.25 μg/mL). However, the content of this component is only 6.3% in E. giganteus and can therefore 
not explain the good activity of this essential oil. It is rather tricyclic sesquiterpenes that are the major 
constituent.  This  is  the  first  report  documenting  the  antitrypanosomal  activity  of  the  tricyclic 
sesquiterpenes‐containing E. giganteus essential oil. The latter was a rich source of compounds such 
as  silphiperfol‐6‐ene,  presilphiperfolan‐8‐ol,  presilphiperfol‐7‐ene,  and  cameroonan‐7‐α‐l with  an 
unusual skeleton (Figure 1) [26]. To date, these compounds have not been biologically investigated. 
Previously,  the  tricyclic sesquiterpene  ledol was suggested  to be  responsible  for  the  trypanocidal 
properties of Hagenia abyssinica (Bruce ex Steud.) J.F.Gmel. essential oil [13]. 
Among the other pure compounds, 1,8‐cineole and terpinen‐4‐ol were inactive against T. brucei 
(IC50 > 100 μg/mL) (Table 2), and this also explained the lack of activity of the A. melegueta and D. 
cinerea essential oils, which are dominated by these compounds. 
Finally, we demonstrated for the first time that the leaf essential oil from the neem tree, which 
showed an IC50 value of 15.21 μg/mL, can be a source of sesquiterpenes such as germacrene B and γ‐
elemene. Since this oil  is completely dominated by sesquiterpenes (97.4%),  it can be assumed that 
they are responsible for its antitrypanosomal activity. Further studies are needed to elucidate their 
mode  of  action  and  the  possibility  of  them  acting  as  lead  compounds  for  the  discovery  of 
antitrypanosomal drugs. 
4. Conclusions 
In conclusion, our biological  investigation  into  the essential oils distilled  from medicinal and 
aromatic plants growing  in Cameroon  identified some  terpenoids as possible  lead compounds of 
natural  antitrypanosomal drugs.  Further  research  is  encouraged  to disclose  their mechanisms  of 
action and in vivo efficacy. 
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Figure 1. Chemical structures of the main essential oil constituents in (a) Aframomum daniellii,
(b) Echinops giganteus, and (c) Azadirachta indica.
E. giganteus as well as A. daniellii essential oils contained the bicyclic sesquiterpene
(E)-caryophyllene (Figure 1), which exhibited good inhibitory properties on T. brucei (IC50 value
of 8.25 µg/mL). However, the content of this compo ent is only 6.3% in E. giganteu and can therefore
not explain the good activity of this essential oil. It is rather tricyclic sesquiterpenes that are the
majo o stituent. This is he first report documenting the antitrypanosomal activity of the tricyclic
sesquiter e e -cont ining E. giganteus essential oil. The latter was a rich source of com ounds such
as silphiperfol-6-e e, presilphiperfolan-8-ol, presilphiperfol-7-ene, and cameroonan-7-α-l with an
unusual skeleton (Figure 1) [26]. To date, these compounds have not been biologically investigated.
Previously, the tricyclic sesquiterpene ledol was suggested to be responsible for the trypanocidal
properties of Hagenia abyssinica (Bruce ex Steud.) J.F.Gmel. essential oil [13].
Among the other pure compounds, 1,8-cineole and terpinen-4-ol were inactive against T. brucei
(IC50 > 100 µg/mL) (Table 2), and this also explained the lack of activity of the A. melegueta and
D. cinerea essential oils, which are dominated by these compounds.
Finally, we demonstrated for the first time that the leaf essential oil from the neem tree, which
showed an IC50 value of 15.21 µg/mL, can be a source of sesquiterpenes such as germacrene B and
γ-elemene. Since this oil is completely dominated by sesquiterpenes (97.4%), it can be assumed
that they are responsible for its antitrypanosomal activity. Further studies are needed to elucidate
their mode of action and the possibility of them acting as lead compounds for the discovery of
antitrypanosomal drugs.
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4. Conclusions
In conclusion, our biological investigation into the essential oils distilled from medicinal and
aromatic plants growing in Cameroon identified some terpenoids as possible lead compounds of
natural antitrypanosomal drugs. Further research is encouraged to disclose their mechanisms of action
and in vivo efficacy.
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